A long-term follow-up of safety and clinical efficacy of NTCELL® [Immunoprotected (Alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's disease
Authors:
- Eoin MulroyEMEoin Mulroy
- Barry SnowBSBarry Snow
- Arnold BokABArnold Bok
- Mark SimpsonMSMark Simpson
- Andrew SmithASAndrew Smith
- Kenneth M. TaylorKTKenneth M. Taylor
- Michelle LockhartMLMichelle Lockhart
- B.B. Janice LamBLB.B. Janice Lam
- Christopher FramptonCFChristopher Frampton
- Gregory FinucaneGFGregory Finucane
- Patrick SchwederPSPatrick Schweder
- Benson ChenBCBenson Chen
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 82, 128-132
Abstract
No abstract availableKeywords
Funding Information
- Living Cell Technologies
- Edmond J. Safra Foundation
- National Institute for Health Research
This publication has 27 references indexed in Scilit:
- Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson’s diseaseBrain, 2020
- Disease Modification for Parkinson's Disease: Axonal Regeneration and Trophic FactorsMovement Disorders, 2018
- Benefits of putaminal GDNF infusion in Parkinson disease are maintained after GDNF cessationNeurology, 2013
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trialThe Lancet Neurology, 2010
- Neurotrophic factors as a therapeutic target for Parkinson's diseaseExpert Opinion on Therapeutic Targets, 2008
- The economic impact of Parkinson's diseaseParkinsonism & Related Disorders, 2007
- Epidemiology of Parkinson's diseaseThe Lancet Neurology, 2006
- Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson diseaseAnnals of Neurology, 2006
- Delivery of Neurotrophic Factors to the Central Nervous SystemClinical Pharmacokinetics, 2001
- What contributes to quality of life in patients with Parkinson's disease?Journal of Neurology, Neurosurgery & Psychiatry, 2000